These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4968865)

  • 1. Comparative studies on inhibitors of fibrinolysis in vitro and in vivo.
    Deutsch E; Fischer M
    Acta Haematol; 1968; 39(1):1-12. PubMed ID: 4968865
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative studies on the antifibrinolytic effect (in vitro and in vivo) of t-AMCHA, phenyl-t-AMCHA, trasylol].
    Moriguchi S
    Nihon Seirigaku Zasshi; 1971; 33(6):355-63. PubMed ID: 5315192
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action.
    Okamoto S; Oshiba S; Mihara H; Okamoto U
    Ann N Y Acad Sci; 1968 Jun; 146(2):414-29. PubMed ID: 5254270
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the mechanism of action of inhibitors of the fibrinolysin system.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Ann N Y Acad Sci; 1968 Jun; 146(2):430-47. PubMed ID: 4239437
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the effect of a new synthetic inhibitor of the fibrinolytic system].
    Fischer M; Pavlu C
    Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
    Skoza L; Tse AO; Semar M; Johnson AJ
    Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antiplasmins].
    Enache F; Cecil P
    Med Interna (Bucur); 1970 Jun; 22(6):667-76. PubMed ID: 4917257
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative clinical-pharmacological studies on synthetic antifibrinolytic agents].
    Markwardt F; Klöcking HP; Landmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):78-83. PubMed ID: 4189376
    [No Abstract]   [Full Text] [Related]  

  • 9. [Animal experiment methods for the testing of fibrinolytic and antifibrinolytic agents].
    Klöcking HP; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):84-9. PubMed ID: 4189378
    [No Abstract]   [Full Text] [Related]  

  • 10. On the action mechanism of some fibrinolysis inhibitors.
    Donner L; Housková J
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):439-46. PubMed ID: 4952977
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of an inhibitor of fibrinolysis upon the intravascular clearance of fibrin monomer in dogs.
    Pratt HW; Celander DR
    J Am Osteopath Assoc; 1970 Jun; 69(10):1049-50. PubMed ID: 5201432
    [No Abstract]   [Full Text] [Related]  

  • 12. 4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures.
    Baumgarten W; Priester LI; Stiller DW; Duncan AE; Ciminera JL; Loeffler LJ
    Thromb Diath Haemorrh; 1969 Nov; 22(2):263-72. PubMed ID: 5380948
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F; Klöcking HP
    Biomed Biochim Acta; 1983; 42(6):725-30. PubMed ID: 6605748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The inhibitors of fibrinolysis: new information on antifibrinolytic agents].
    Giacomazzi G
    Haematologica; 1968; 53(7):489-533. PubMed ID: 4976851
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metabolism of fibrinogen following administration of brain phospholipids in combination with an antifibrinolytic agent (AMCHA)].
    Cultrera G; Lampugnani P
    Arzneimittelforschung; 1973 Mar; 23(3):445-7. PubMed ID: 4740135
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the mechanism of the effect of various inhibitors of fibrinolysis].
    Donner L; Housková J
    Sb Lek; 1967; 69(11):343-51. PubMed ID: 5299789
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of the fibrinogen splitting products in the blood plasma in hyperfibrinolysis].
    Veremienko KN; Varetskaia TV; Kizim AI; Gerasimenko NG
    Ukr Biokhim Zh; 1976; 48(3):337-42. PubMed ID: 134480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic inhibition of urokinase-induced fibrinolysis by epsilon-aminocaproic acid; distinction from tissue plasminogen activator.
    Thorsen S; Astrup T
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):811-3. PubMed ID: 5773672
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of tissue penetrability and therapeutic dose of epsilon-aminocaproic acid, AMCHA and trasylol with the help of direct homogenate- plasma-thromboelastography examplified on the fibrinolytically active myometrium].
    Schmidt-Matthiesen H; Schreinert B
    Klin Wochenschr; 1968 Jul; 46(13):730-1. PubMed ID: 5306518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.